Medline Inc. (MDLN) financial statements and ratios from SEC XBRL: revenue $28.43B (TTM), net margin 4.1%, revenue growth 11.6% YoY, P/E 29.8. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $28.43B |
| Net Margin | 4.1% |
| Revenue Growth (YoY) | 11.6% |
| FCF Growth (YoY) | 37.1% |
| P/E Ratio | 29.8 |
| EV / EBITDA | 11.3 |
| Price / Book | 1.48 |
| Price / Sales | 0.96 |
| FCF Yield | 7.9% |
| DCF Value (model) | $17.76 |
| DCF Upside vs Price | -45.7% |
| Altman Z-Score | 2.01 (grey) |
| Sector P/E (Healthcare) | 21.6 |
MDLN overview · MDLN earnings · MDLN KPIs · MDLN investor relations · MDLN ownership · MDLN peers · MDLN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.